Osteoarthritis (OA) is primarily a degenerative disease triggered by joint inflammation and oxidative stress. While
Aster glehni is an edible and traditionally medicinal herb, the beneficial effect of
A. glehni on OA progression remains unknown. This study aimed to investigate the effect of
[...] Read more.
Osteoarthritis (OA) is primarily a degenerative disease triggered by joint inflammation and oxidative stress. While
Aster glehni is an edible and traditionally medicinal herb, the beneficial effect of
A. glehni on OA progression remains unknown. This study aimed to investigate the effect of
A. glehni extract (AGE) and its primary biological compound—3,5-dicaffeoylquinic acid (3,5-DCQA)—on inflammation and oxidative stress in chondrocytes. AGE effectively inhibited the expression of interleukin (IL)-6, cyclooxygenase (COX)-2, matrix metalloproteinase (MMP)-1, and MMP-13 in chondrocytes stimulated by IL-1β for 24 h. In contrast, 3,5-DCQA did not inhibit IL-6, COX-2, and MMP expressions under the same conditions. However, when chondrocytes were stimulated by IL-1β for a short duration (6 h), 3,5-DCQA suppressed IL-6, COX-2, and MMP expressions. The inhibition of IL-6, COX-2, and MMP expressions by AGE was associated with the p38 kinase and nuclear factor-κB signaling pathways, but not ERK and JNK signaling pathways. Furthermore, AGE prevented cell apoptosis and reduced intracellular reactive oxygen species levels in chondrocytes induced by hydrogen peroxide (H
2O
2). AGE restored the decreased superoxide dismutase 1 and catalase mRNA expressions caused by H
2O
2. Collectively, AGE may protect against cartilage deterioration by inhibiting inflammation and oxidative stress, making it a promising therapeutic agent for alleviating OA.
Full article
